Daniel R. Couriel

Daniel R. Couriel is a Tenured Associate Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah's Department of Internal Medicine. He serves as Medical Director for the Center of Cellular Therapy and Regenerative Medicine at Huntsman Cancer Institute and Director of the Utah Blood and Marrow Transplantation Program. His leadership roles include board memberships with the American Society of Cellular Therapy and Transplantation (ASTCT) and the Foundation for Accreditation of Cellular Therapy (FACT).

Dr. Couriel received his MD from Universidad de Buenos Aires (1987), an MS in Biostatistics from University of Michigan (year unspecified), and an MBA from University of Utah Eccles School of Business (2021). He completed residencies at George Washington University Hospital and University of Buenos Aires, followed by fellowships at Tufts University, NHLBI, and Johns Hopkins University.

His research focuses on graft-versus-host disease (GVHD) and CAR T-cell therapy, with over 100 peer-reviewed publications on topics like:

• GVHD biomarker identification
• Comparative transplant outcomes
• Photopheresis applications
• Lymphoma treatment protocols
• Transplantation supportive care
• Biomarker validation studies

Scientific contributions include NIH Consensus Project committees on Chronic GVHD and leadership roles in GVHD subcommittees. His clinical practice involves hematologic malignancies and transplantation medicine, with patient ratings highlighting expertise in:

• Chronic Lymphocytic Leukemia
• Blood and Marrow Transplantation
• Hodgkin/Non-Hodgkin Lymphoma
• CAR T-cell Therapy